Diabetic neuropathy: molecular approach a treatment opportunity

ST Méndez-Morales, JC Pérez-De Marcos… - Vascular …, 2022 - Elsevier
Diabetic neuropathy (DN) encompasses a group of clinical or subclinical manifestations
involving a dysfunction in the peripheral nervous system. The cause of the dysfunction is the …

Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus

X Guo, Y Xing, W Jin - Frontiers in Endocrinology, 2023 - frontiersin.org
Diabetic microangiopathy is a typical and severe problem in diabetics, including diabetic
retinopathy, diabetic nephropathy, diabetic neuropathy, and diabetic cardiomyopathy …

[HTML][HTML] Kallistatin as a Potential Marker of Therapeutic Response During Alpha-Lipoic Acid Treatment in Diabetic Patients with Sensorimotor Polyneuropathy

M Hernyák, LI Tóth, S Csiha, Á Molnár… - International Journal of …, 2024 - mdpi.com
Diabetic sensorimotor neuropathy (DSPN) is strongly associated with the extent of cellular
oxidative stress and endothelial dysfunction in type 2 diabetes (T2DM). Alpha-lipoic acid …

[PDF][PDF] Az oxidatív stressz és az endothel diszfunkció markereinek változása alfa-liponsav kezelés és mozgásterápia hatására diabéteszes polyneuropathiás …

M Ágnes - dea.lib.unideb.hu
HR heart rate (pulzus) hsCRP high-sensitivity C-reactive protein (nagy érzékenységű C-
reaktív fehérje) ICAM intercellular adhesion molecule (intercelluláris adhéziós molekula) IDF …